United States · FDA National Drug Code directory
LASTACAFT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0023-4291_447257d6-c313-499e-8a48-499badb37766
- Product NDC
- 0023-4291
- Form
- SOLUTION/ DROPS
- Composition / generic term
- alcaftadine
- Labeler
- Allergan, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20211201
- Source listing expiry
- 20261231
Source-listed ingredients
- ALCAFTADINE — 2.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (0023-4291-01) / 1 mL in 1 BOTTLE, PLASTIC · 0023-4291-01
- 1 BOTTLE, PLASTIC in 1 CARTON (0023-4291-05) / 5 mL in 1 BOTTLE, PLASTIC · 0023-4291-05
- 1 BOTTLE, PLASTIC in 1 CARTON (0023-4291-06) / 5 mL in 1 BOTTLE, PLASTIC · 0023-4291-06
- 2 BOTTLE, PLASTIC in 1 CARTON (0023-4291-07) / 5 mL in 1 BOTTLE, PLASTIC · 0023-4291-07
- 2 BOTTLE, PLASTIC in 1 CARTON (0023-4291-10) / 5 mL in 1 BOTTLE, PLASTIC · 0023-4291-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →